TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28877238

Group type: EXPERIMENTAL
Intervention: Recruitment manoeuvre (RM) with positive end expiratory pressure (PEEP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Positive end expiratory pressure (PEEP) without recruitment manoeuvre (RM)
Number of subjects: 60
Study: 25304832

Group type: EXPERIMENTAL
Intervention: Preoperative physical activity intervention (PAI) for 6 weeks, including weekly individual face-to-face sessions with tailored instruction in behavioral strategies
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Preoperative physical activity intervention (PAI) for 6 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard presurgical care (SC)
Number of subjects: 75
Study: 23593633

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix allograft (ADMA) with coronally positioned flap (CPF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Coronally positioned flap (CPF) alone
Number of subjects: 20
Study: 21311347

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) with a frequency of 30 Hz and an amplitude of 6.5 mm in 4 bouts of 30 seconds with 30 seconds of rest between bouts, followed by 3 countermovement jumps (CMJs) with different rest intervals (immediate, 30 seconds, 1 minute, 2 minutes, or 4 minutes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control condition: squats with no WBV
Number of subjects: 30
Study: 19820017

Group type: EXPERIMENTAL
Intervention: 1 mg anastrozole daily
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 16829029

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 mcg of selenomethionine daily)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 15277409

Group type: EXPERIMENTAL
Intervention: Low-glycemic index (LGI) diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-glycemic index (HGI) diet
Number of subjects: 12
Study: 11576045

Group type: EXPERIMENTAL
Intervention: Naloxone 0.4 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Naloxone 10 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 9150660

Group type: EXPERIMENTAL
Intervention: High lighting levels
Number of subjects: 25

Group type: COMPARATOR
Intervention: Dim room lighting
Number of subjects: 25

Group type: COMPARATOR
Intervention: Dark lighting
Number of subjects: 25
Study: 7911175

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 134
Study: 3582483

Group type: EXPERIMENTAL
Intervention: Ketotifen syrup 1 mg b.i.d. for 8 days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Aminophylline syrup 6 mg/kg
Number of subjects: 6
Study: 30035416

Group type: EXPERIMENTAL
Intervention: Kidney transplant recipients
Number of subjects: 110

Group type: COMPARATOR
Intervention: Hemodialysis patients (Control)
Number of subjects: 110
Study: 28842086

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided nerve block (NB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 40
Study: 26256138

Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo (simple surface touching)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control (routine care)
Number of subjects: 96
Study: 23743162

Group type: EXPERIMENTAL
Intervention: Yiqi Huaju Formula (CHF)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 43
Study: 21445642

Group type: EXPERIMENTAL
Intervention: Inhaled sevoflurane (group S)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous propofol (group P)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous midazolam (group M)
Number of subjects: 60
Study: 18159096

Group type: EXPERIMENTAL
Intervention: Aspirin and cilostazol (group I, n=141)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Aspirin and clopidogrel (group II, n=139)
Number of subjects: 280
Study: 16957901

Group type: EXPERIMENTAL
Intervention: Piperacillin-resistant Pseudomonas strains
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piperacillin-susceptible Pseudomonas strains
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Piperacillin resistance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Piperacillin-resistant and susceptible strains
Number of subjects: 0
Study: 14610641

Group type: EXPERIMENTAL
Intervention: Ibandronate (2 mg) injections every 3 months plus daily calcium supplements (500 mg)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Daily oral alfacalcidol (1 microg) plus daily calcium supplements (500 mg)
Number of subjects: 115
Study: 10913058

Group type: EXPERIMENTAL
Intervention: Intensive exercise programme
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conservative exercise programme
Number of subjects: 64
Study: 8682682

Group type: EXPERIMENTAL
Intervention: Modified positioning and mobilization routine (head of the bed elevated to 45 degrees, ambulated briefly at bedside 4 hours after angiography)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (6 hours of bed rest after cardiac angiography)
Number of subjects: 29
Study: 1410326

Group type: EXPERIMENTAL
Intervention: Iotrolan
Number of subjects: 158

Group type: COMPARATOR
Intervention: Iopamidol
Number of subjects: 158
Study: 3885173

Group type: EXPERIMENTAL
Intervention: Combination vindesine and cisplatin (DDP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single-agent vindesine (DVA)
Number of subjects: 0
Study: 28671753

Group type: EXPERIMENTAL
Intervention: Strategy-A (glucose-dependent therapies with a non-sulphonylurea OAM and a glucagon-like peptide-1 receptor agonist)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Strategy-B (non-glucose-dependent therapies with sulphonylurea and insulin glargine)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Strategy-A
Number of subjects: 192

Group type: COMPARATOR
Intervention: Strategy-B
Number of subjects: 192
Study: 27244793

Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention (1 group session and 8 individual sessions)
Number of subjects: 1355

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 1355
Study: 25014995

Group type: EXPERIMENTAL
Intervention: Web-based ESRA-C intervention delivered to patients' homes or to a tablet in clinic.
Number of subjects: 517

Group type: COMPARATOR
Intervention: ESRA-C assessment only (control group).
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Web-based ESRA-C intervention.
Number of subjects: 517

Group type: COMPARATOR
Intervention: Control group (ESRA-C assessment only).
Number of subjects: 517

Group type: EXPERIMENTAL
Intervention: Patients' verbal reports (intervention group).
Number of subjects: 517
Study: 22199163

Group type: EXPERIMENTAL
Intervention: High-intensity resistance training for 18 weeks
Number of subjects: 10
Study: 20567172

Group type: EXPERIMENTAL
Intervention: Didactic study arm using the cystoscopy model
Number of subjects: 29
Study: 18672827

Group type: EXPERIMENTAL
Intervention: Multimedia programme
Number of subjects: 30

Group type: COMPARATOR
Intervention: Leaflet group
Number of subjects: 30
Study: 15792209

Group type: EXPERIMENTAL
Intervention: Minimally invasive technique with a posterolateral incision no longer than 10 cm
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard posterolateral approach
Number of subjects: 120
Study: 14563575

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene (PTFE)‐membrane‐covered stent (Jostent Stentgraft)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Conventional stent (Jostent Flex)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Both groups (PTFE-membrane-covered stent and conventional stent)
Number of subjects: 211
Study: 10793318

Group type: EXPERIMENTAL
Intervention: Pindolol augmentation (2.5 mg x 3/d) with paroxetine (60 mg/d)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo augmentation with paroxetine (60 mg/d)
Number of subjects: 14
Study: 8899094

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg twice daily for 1 week, then once daily for 3 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ranitidine 300 mg twice daily for 1 week, then once daily for 3 weeks
Number of subjects: 100
Study: 1701718

Group type: EXPERIMENTAL
Intervention: Model-based method for the detection of sleep phasic events (vertex waves and K complexes)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Model-based method for the detection of sleep phasic events
Number of subjects: 6
Study: 6194757

Group type: EXPERIMENTAL
Intervention: Combination antibiotic therapy (sulbenicillin and amikacin) with S‐sulfonated gamma‐globulin (Group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Combination antibiotic therapy (sulbenicillin and amikacin) without S‐sulfonated gamma‐globulin (Group B)
Number of subjects: 50
Study: 31566309

Group type: EXPERIMENTAL
Intervention: Encorafenib, binimetinib, and cetuximab (triplet-therapy group)
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Encorafenib and cetuximab (doublet-therapy group)
Number of subjects: 665

Group type: COMPARATOR
Intervention: Control group (cetuximab and irinotecan or cetuximab and FOLFIRI)
Number of subjects: 665
Study: 28657216

Group type: EXPERIMENTAL
Intervention: Rikkunshito with standard antiemetics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (antiemetics only)
Number of subjects: 0
Study: 25897047

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Near-infrared vascular imaging
Number of subjects: 418
Study: 23411644

Group type: EXPERIMENTAL
Intervention: Spinal mobilization techniques of the upper cervical spine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Massage therapy of the neck region
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Functional Neck Disability Index (NDI)
Number of subjects: 36
Study: 22134569

Group type: EXPERIMENTAL
Intervention: GA 70% peeling
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Tretinoin 1% peeling
Number of subjects: 63
Study: 19549306

Group type: EXPERIMENTAL
Intervention: Phytotherapeutic combination treatment
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 17578985

Group type: EXPERIMENTAL
Intervention: Tibial motor response
Number of subjects: 26

Group type: COMPARATOR
Intervention: Peroneal motor response
Number of subjects: 26
Study: 15197195

Group type: COMPARATOR
Intervention: GV (gemcitabine 1000 mg/m(2) + vinorelbine 25 mg/m(2) on days 1 and 8 every 3 weeks)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: GVP (gemcitabine 1000 mg/m(2) + vinorelbine 25 mg/m(2) + cisplatin 75 mg/m(2) on day 2 every 3 weeks)
Number of subjects: 300

Group type: COMPARATOR
Intervention: GV
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: GVP
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: GV and GVP
Number of subjects: 300
Study: 15489869

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg/kg intravenously every 8 h
Number of subjects: 110

Group type: COMPARATOR
Intervention: Granisetron 10 microg/kg intravenously daily
Number of subjects: 110
Study: 10077963

Group type: EXPERIMENTAL
Intervention: Low-energy extracorporeal shockwave therapy (ESWT) with 250 impulses of 0.04 mJ/mm2
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo treatment with shock-wave impact inhibited by a neopren insert
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low-energy extracorporeal shockwave therapy (ESWT)
Number of subjects: 50
Study: 8834820

Group type: EXPERIMENTAL
Intervention: High-risk strategy package (HR)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Tamil Nadu Government package (TNG)
Number of subjects: 294

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 294
Study: 2036345

Group type: EXPERIMENTAL
Intervention: Vernier targets
Number of subjects: 25
Study: 7235851

Group type: EXPERIMENTAL
Intervention: Treatment on a research unit
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard adult inpatient (nonresearch) units
Number of subjects: 56
Study: 31793165

Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combination of lixisenatide and insulin glargine
Number of subjects: 28
Study: 30876869

Group type: EXPERIMENTAL
Intervention: Low-dose fascia iliaca compartment block (FICB)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 28069051

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine plus basic treatment (steroids and 5-aminosalicylic acid)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Azathioprine plus basic treatment (steroids and 5-aminosalicylic acid)
Number of subjects: 120
Study: 26750398

Group type: EXPERIMENTAL
Intervention: Hip external rotator exercise program (5 times per week for four weeks)
Number of subjects: 28
Study: 25090366

Group type: EXPERIMENTAL
Intervention: Telephone-administered supportive-expressive group therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Coping effectiveness group training
Number of subjects: 0
Study: 23102179

Group type: EXPERIMENTAL
Intervention: 6 g ground cinnamon
Number of subjects: 30

Group type: COMPARATOR
Intervention: Plain cereal (control)
Number of subjects: 30
Study: 19553931

Group type: EXPERIMENTAL
Intervention: PPAR-agonist treatment
Number of subjects: 2688

Group type: COMPARATOR
Intervention: Non-PPAR drugs
Number of subjects: 2688

Group type: EXPERIMENTAL
Intervention: Increase in adiponectin levels
Number of subjects: 2688
Study: 17616069

Group type: EXPERIMENTAL
Intervention: Intravenous treatment with 500 mg of sacharose ferric oxide (Venofer)
Number of subjects: 50
Study: 15015147

Group type: EXPERIMENTAL
Intervention: Dietary protein restriction (0.71 g x kg(‐1) fat‐free mass x d(‐1))
Number of subjects: 2

Group type: COMPARATOR
Intervention: Ample American-style protein intake (1.67 g x kg(‐1) fat‐free mass x d(‐1))
Number of subjects: 2
Study: 11930875

Group type: COMPARATOR
Intervention: Standard pancreaticoduodenectomy
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard lymph node dissection
Number of subjects: 59

Group type: COMPARATOR
Intervention: Different types of pancreatic-enteric reconstruction
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Prophylactic gastrojejunostomy
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Chemical splanchnicectomy
Number of subjects: 59
Study: 9537309

Group type: EXPERIMENTAL
Intervention: 1 mg zinc (n = 68)
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: 5 mg zinc (n = 71)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo (n = 66)
Number of subjects: 205
Study: 7702150

Group type: EXPERIMENTAL
Intervention: Thoracic epidural infusion of bupivacaine 0.2% with fentanyl 10 micrograms.ml‐1
Number of subjects: 33

Group type: COMPARATOR
Intervention: Lumbar epidural infusion of bupivacaine 0.2% with fentanyl 10 micrograms.ml‐1
Number of subjects: 33
Study: 29482412

Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) training, 2 times a week for 12 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 16
Study: 28404157

Group type: EXPERIMENTAL
Intervention: Weekly nab-paclitaxel (100 mg/m2, on days 1, 8, and 15 of a 28-day cycle)
Number of subjects: 741

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel every 3 weeks (260 mg/m2, on day 1 of a 21-day cycle)
Number of subjects: 741

Group type: COMPARATOR
Intervention: Weekly solvent-based paclitaxel (80 mg/m2, on days 1, 8, and 15 of a 28-day cycle)
Number of subjects: 741
Study: 25739878

Group type: EXPERIMENTAL
Intervention: Low dose measles-virus-based candidate vaccine (1.5 x 10^4 TCID50 per 0.05 mL)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Medium dose measles-virus-based candidate vaccine (7.5 x 10^4 TCID50 per 0.25 mL)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High dose measles-virus-based candidate vaccine (3.0 x 10^5 TCID50 per 1.0 mL)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Measles-virus-based candidate vaccine (all doses)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Priorix (active comparator)
Number of subjects: 42
Study: 23128844

Group type: EXPERIMENTAL
Intervention: Nasal high flow (nHF) ventilation for 8 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spontaneous breathing
Number of subjects: 0
Study: 20338670

Group type: EXPERIMENTAL
Intervention: Educational intervention programme consisting of a series of lectures and videos
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (completed the same intervention programme after the study)
Number of subjects: 0
Study: 17415030

Group type: EXPERIMENTAL
Intervention: MIST Therapy plus standard of wound care
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard of wound care alone
Number of subjects: 70
Study: 16313144

Group type: EXPERIMENTAL
Intervention: HOT (30.3 degrees C, 76% RH)
Number of subjects: 13

Group type: COMPARATOR
Intervention: CONTROL (20.4 degrees C, 60% RH)
Number of subjects: 13
Study: 12387552

Group type: EXPERIMENTAL
Intervention: Prenatal and infancy home visiting by nurses
Number of subjects: 0
Study: 10429608

Group type: EXPERIMENTAL
Intervention: Postoperative splinting for 4 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: No postoperative splinting
Number of subjects: 82
Study: 7473919

Group type: EXPERIMENTAL
Intervention: Human Growth Hormone (HGH) administration
Number of subjects: 69

Group type: COMPARATOR
Intervention: No Human Growth Hormone (Control)
Number of subjects: 69
Study: 2407228

Group type: EXPERIMENTAL
Intervention: Early shoulder mobilization (initiated on postoperative day 2)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Delayed shoulder mobilization (initiated on postoperative day 5)
Number of subjects: 57
Study: 6794552

Group type: EXPERIMENTAL
Intervention: Sodium acetate (90 mEq/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31859245

Group type: EXPERIMENTAL
Intervention: 2.5 mg/kg belantamab mafodotin
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: 3.4 mg/kg belantamab mafodotin
Number of subjects: 196
Study: 30667335

Group type: EXPERIMENTAL
Intervention: Vancouver risk calculator (VRC)
Number of subjects: 2813

Group type: COMPARATOR
Intervention: ACR Lung Imaging Reporting and Data System (Lung‐RADS)
Number of subjects: 2813
Study: 28799810

Group type: EXPERIMENTAL
Intervention: Whole body vibration training (WBVT) on an active Power Plate® platform.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham intervention on an inactive Power Plate® platform.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Whole body vibration training (WBVT) and sham intervention.
Number of subjects: 19
Study: 25380179

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 53
Study: 25633544

Group type: EXPERIMENTAL
Intervention: REBT-based intervention (8 sessions weekly: 6 individual and 2 group sessions)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: REBT-based intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 21708047

Group type: EXPERIMENTAL
Intervention: Regular reporting of spirometric results combined with smoking cessation advice by a primary care physician
Number of subjects: 485

Group type: COMPARATOR
Intervention: Brief structured advice about giving up smoking (Control)
Number of subjects: 485
Study: 19995206

Group type: EXPERIMENTAL
Intervention: Cataract surgery with intra-ocular lenses (IOLs)
Number of subjects: 4738

Group type: EXPERIMENTAL
Intervention: Cataract surgery in non-governmental organizations (NGO)/private facilities
Number of subjects: 4738

Group type: EXPERIMENTAL
Intervention: Recent cataract surgery
Number of subjects: 4738

Group type: EXPERIMENTAL
Intervention: Older age, literacy, and urban residence
Number of subjects: 4738

Group type: EXPERIMENTAL
Intervention: Refractive error and posterior capsule opacification
Number of subjects: 4738
Study: 17376548

Group type: EXPERIMENTAL
Intervention: Low-osmolar monomeric contrast medium (iomeprol-350, n=60)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Iso-osmolar dimeric contrast medium (iodixanol-320, n=60)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Iomeprol-300 (n=49)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Iodixanol-320 (n=47)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Iomeprol (n=60)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Iodixanol (n=60)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Iomeprol (n=49)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Iodixanol (n=47)
Number of subjects: 216
Study: 15839848

Group type: COMPARATOR
Intervention: Continuous Flicker Method (CFM)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Forced Choice Method (FCM)
Number of subjects: 56
Study: 11927223

Group type: EXPERIMENTAL
Intervention: Oral valacyclovir 2000 mg four times daily for 90 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Oral acyclovir 200 mg four times daily for 90 days
Number of subjects: 27
Study: 9793814

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg plus droperidol 0.625 mg (Group OD)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: droperidol 0.625 mg plus metoclopramide 10 mg (Group DM)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: perphenazine 5 mg (Group P)
Number of subjects: 212
Study: 8569644

Group type: EXPERIMENTAL
Intervention: Inhaled nedocromil sodium 16 mg/day
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Inhaled nedocromil sodium 8 mg/day
Number of subjects: 22
Study: 2692894

Group type: EXPERIMENTAL
Intervention: Peripatellar methylprednisolone injection
Number of subjects: 38

Group type: COMPARATOR
Intervention: Intra-articular methylprednisolone injection
Number of subjects: 38
Study: 1083668

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery (subgroup with marked ischemic dysfunction)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Medically treated control group
Number of subjects: 78
Study: 31324040

Group type: EXPERIMENTAL
Intervention: Pectin supplementation (15 g/day for four weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100